Financial Architects (New Jersey)’s Inovio Pharmaceuticals INO Stock Holding History

Financial Architects (New Jersey)’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4	Closed	–	–	1330
2019 Q1	$0	Hold	4	–	–	﹤0.01%	1468
2018 Q4	$0	Hold	4	–	–	﹤0.01%	1407
2018 Q3	$0	Hold	4	–	–	﹤0.01%	1457
2018 Q2	$0	Hold	4	–	–	﹤0.01%	1410
2018 Q1	$0	Hold	4	–	–	﹤0.01%	1486
2017 Q4	$0	Hold	4	–	–	﹤0.01%	1536
2017 Q3	$0	Hold	4	–	–	﹤0.01%	1532
2017 Q2	$0	Hold	4	–	–	﹤0.01%	1560
2017 Q1	$0	Hold	4	–	–	﹤0.01%	1593
2016 Q4	$0	Hold	4	–	–	﹤0.01%	1444
2016 Q3	$0	Hold	4	–	–	﹤0.01%	1475
2016 Q2	$0	Buy	+4	New	+$486	﹤0.01%	1461

Other funds holding INO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Financial Architects (New Jersey)'s INO Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Inovio Pharmaceuticals (INO) in Q2 2019, closing a stake of 4 shares.

Financial Architects (New Jersey) first reported a position in INO in Q2 2016 and held it in 12 quarters. The position peaked at $0 in Q1 2019. 126 funds tracked by Wall St. Rank hold INO as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Inovio Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 4 Inovio Pharmaceuticals shares in Q2 2019.
Financial Architects (New Jersey) first reported a position in Inovio Pharmaceuticals in Q2 2016 and held it in 12 quarters.
Financial Architects (New Jersey)'s Inovio Pharmaceuticals position peaked at $0 in Q1 2019.
126 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.